181 related articles for article (PubMed ID: 25401478)
1. Acute severe methotrexate toxicity in patients with psoriasis: a case series and discussion.
Yélamos O; Català A; Vilarrasa E; Roé E; Puig L
Dermatology; 2014; 229(4):306-9. PubMed ID: 25401478
[TBL] [Abstract][Full Text] [Related]
2. [Apparent worsening of psoriasis lesions revealing methotrexate overdosage].
Haber R; Baroudjian B; Battistella M; Bagot M; Petit A
Ann Dermatol Venereol; 2018 Feb; 145(2):104-108. PubMed ID: 28917574
[TBL] [Abstract][Full Text] [Related]
3. Ulcerations due to methotrexate toxicity in a psoriasis patient.
Souza CF; Suarez OM; Silva TF; Gorenstein AC; Quintella LP; Avelleira JC
An Bras Dermatol; 2016; 91(3):375-7. PubMed ID: 27438211
[TBL] [Abstract][Full Text] [Related]
4. Acute methotrexate toxicity seen as plaque psoriasis ulceration and necrosis: A diagnostic clue.
Fridlington JL; Tripple JW; Reichenberg JS; Hall CS; Diven DG
Dermatol Online J; 2011 Nov; 17(11):2. PubMed ID: 22136858
[TBL] [Abstract][Full Text] [Related]
5. Methotrexate-induced pancytopenia: a case series of 46 patients.
Ajmani S; Preet Singh Y; Prasad S; Chowdhury A; Aggarwal A; Lawrence A; Misra R; Mishra R; Agarwal V
Int J Rheum Dis; 2017 Jul; 20(7):846-851. PubMed ID: 28261918
[TBL] [Abstract][Full Text] [Related]
6. Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis.
Prodanovich S; Ma F; Taylor JR; Pezon C; Fasihi T; Kirsner RS
J Am Acad Dermatol; 2005 Feb; 52(2):262-7. PubMed ID: 15692471
[TBL] [Abstract][Full Text] [Related]
7. [Methotrexate: safe if prescribed correctly].
Verduijn MM; van den Bemt BJ; Dijkmans BA; van der Waal RI; Horikx A
Ned Tijdschr Geneeskd; 2009; 153():A695. PubMed ID: 19785857
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous erosions: a herald for impending pancytopenia in methotrexate toxicity.
Shiver MB; Hall LA; Conner KB; Brown GE; Cheung WL; Wirges ML
Dermatol Online J; 2014 Jul; 20(7):. PubMed ID: 25046458
[TBL] [Abstract][Full Text] [Related]
9. Stevens-Johnson syndrome-like exanthema secondary to methotrexate histologically simulating acute graft-versus-host disease.
Hani N; Casper C; Groth W; Krieg T; Hunzelmann N
Eur J Dermatol; 2000; 10(7):548-50. PubMed ID: 11056429
[TBL] [Abstract][Full Text] [Related]
10. Early-onset pancytopenia and skin ulcer following low-dose methotrexate therapy.
Hocaoglu N; Atilla R; Onen F; Tuncok Y
Hum Exp Toxicol; 2008 Jul; 27(7):585-9. PubMed ID: 18829735
[TBL] [Abstract][Full Text] [Related]
11. Focal skin toxicity related to methotrexate sparing psoriatic plaques.
Truchuelo T; Alcántara J; Moreno C; Vano-Galván S; Jaén P
Dermatol Online J; 2010 Jun; 16(6):16. PubMed ID: 20579471
[TBL] [Abstract][Full Text] [Related]
12. Acute mucocutaneous methotrexate toxicity associated with interface dermatitis and numerous eosinophils.
Ferguson NN; Asarch A; VanBeek M; Swick BL
Am J Dermatopathol; 2013 Jun; 35(4):e63-6. PubMed ID: 23221488
[TBL] [Abstract][Full Text] [Related]
13. Methotrexate in psoriasis: 26 years' experience with low-dose long-term treatment.
Haustein UF; Rytter M
J Eur Acad Dermatol Venereol; 2000 Sep; 14(5):382-8. PubMed ID: 11305380
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of systemic methotrexate in two fixed doses of 10 mg or 25 mg orally once weekly in adult patients with severe plaque-type psoriasis: a prospective, randomized, double-blind, dose-ranging study.
Dogra S; Krishna V; Kanwar AJ
Clin Exp Dermatol; 2012 Oct; 37(7):729-34. PubMed ID: 22830389
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of infliximab vs. methotrexate in patients with moderate-to-severe plaque psoriasis: results of an open-label, active-controlled, randomized trial (RESTORE1).
Barker J; Hoffmann M; Wozel G; Ortonne JP; Zheng H; van Hoogstraten H; Reich K
Br J Dermatol; 2011 Nov; 165(5):1109-17. PubMed ID: 21910713
[TBL] [Abstract][Full Text] [Related]
16. [4pp Mucocutaneous manifestations of methotrexate toxicity].
Ferrari B; Kogan N; Veira RC; Luna PC; Larralde M; Cuesta MG; Díaz P; Rossi MV; Aloise I
Medicina (B Aires); 2018; 78(1):50-53. PubMed ID: 29360079
[TBL] [Abstract][Full Text] [Related]
17. Weekly vs. daily administration of oral methotrexate (MTX) for generalized plaque psoriasis: a randomized controlled clinical trial.
Radmanesh M; Rafiei B; Moosavi ZB; Sina N
Int J Dermatol; 2011 Oct; 50(10):1291-3. PubMed ID: 21950300
[TBL] [Abstract][Full Text] [Related]
18. Pancytopenia associated with low dose methotrexate therapy. A regional survey.
al-Awadhi A; Dale P; McKendry RJ
J Rheumatol; 1993 Jul; 20(7):1121-5. PubMed ID: 8371202
[TBL] [Abstract][Full Text] [Related]
19. A pilot study of pharmacokinetically guided dosing of oral methotrexate in the initial phase of psoriasis treatment.
Hroch M; Chladek J; Simkova M; Vaneckova J; Grim J; Martinkova J
J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):19-24. PubMed ID: 18031504
[TBL] [Abstract][Full Text] [Related]
20. Severe pancytopenia in a patient taking low dose methotrexate and probenecid.
Basin KS; Escalante A; Beardmore TD
J Rheumatol; 1991 Apr; 18(4):609-10. PubMed ID: 2066953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]